Effects of IL-9 on CLL correlate with activation of the JAK/STAT pathways and microRNAs

来源 :22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) | 被引量 : 0次 | 上传用户:limingxing0623
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To determine the function of IL-9 in the development of CLL through STAT3, STAT6/miR-155, and miR-21 pathways.Methods: Data of patients who were diagnosed with CLL at Shandong Provincial Hospital from 2010 January to 2012July were collected.All patients were untreated, and their lymphocytes exceeded 90%.We measured the serum levels of IL-9 in 47 patients with CLL and healthy controls using ELISA.Expression of pSTAT3 and pSTAT6 in the peripheral blood mononuclear cells (PBMCs) from 20 CLL patients were detected using Western blot, with upregulation of IL-9and B cells from healthy samples.MiRNA155 and miRNA21expression in 20 patient and healthy samples was analyzed using real-time quantitative PCR.IL-9 production was determined by Western blot and real-time quantitative PCR in CLL and miR-transfected CLL cells, which were treated with IL-9 at various time points.These cells were then exposed to WP1066 or A77-1726 for 48 h to detect the IL-9 secretion.Cell proliferation was finally observed using CCK-8 incorporation assay.Cell apoptosis was investigated using annexinⅤ-FITC/PI staining followed by flow cytometry.
其他文献
Objective: To investigate the therapeutic efficacy of rituximab combined with autologous peripheral blood stem cell transplantation (APBSCT) in the treatment of patients with aggressive B-cell non-Hod
会议
Objective: The therapeutic effects of refractory/recurrent myeloid leukemia, which was salvaged by allogeneic hematopoietic stem cell transplantation (HSCT), are usually poor, with high relapse rate a
会议
Objective: To investigate the clinical features and prognostic factors of primary small intestine lymphoma (PSIL).Methods: The clinical data of 48 cases with PSIL were studied retrospectively.All pati
会议
Objective: To assess the proliferative activity of diffuse large B cell lymphoma (DLBCL) according to Cdc7 and Mcm2expression using immunihistochemistry (IHC) and real-time PCR.The potential value of
会议
Objective: To compare the efficacy and safety between R-GemOx and RICE regime in the treatment of relapsed or refractory non-Hodgkins lymphoma (NHL).Methods: A total of 65 cases with relapsed and refr
会议
Objective: To determine the clinical characteristics and prognostic factors of patients with secondary malignant neoplasm (SMN) following non-Hodgkins lymphoma (NHL).Methods: Clinical data of patients
会议
Objective: To evaluate the antitumor effect of lenalidomide(LEN) in combination with bortezomib (BTZ) on T-cell lymphoma cells and their microenvironment.The synergistic or antagonistic effects of the
会议
Objective: To explore the morbidity, clinical features, treatment,and prognostic factors of primary cutaneous B-cell lymphoma(PCBCL).Methods: A total of 31 patients with PCBCL were registered in Tianj
会议
Objective: To explore the morbidity, clinical features,metastasis, treatment, and prognostic factors of leg-type primary cutaneous diffuse large B-cell lymphoma (PCLBCL).Methods: Four patients with le
会议
Objective: To determine the effect of FoxM1 downregulation on curcumin-induced growth and angiogenesis inhibition of acute myeloid leukemia (AML) cells.Methods: The inhibitory effects of curcumin were
会议